Members of the Our Leaders oversee all processes within the Biokinetica Early Phase Institute and are the primary point of contact for clients. All documents provided by the sponsor are reviewed by Dr. Georg Golor, Dr. Monika Tomaszewska-Kiecana and Agnieszka Kulesza.
Responses to client requests are usually provided within a few working days, however, the response time may vary depending on the complexity of the requested study (complex schedule of procedures, recruitment of specific patient population, etc.).
Has more than 30 years of experience in the international business and management.
Established the international life science businesses in Europe, Asia and USA.
Georg Golor, MD, PhD
Dr. Golor has over 21 years’ experience in clinical pharmacology. He has extensive knowledge in early drug development and conduct of early-phase trials gained during several years’ tenure as Senior Director Study Operations (7 years’ experience) and as Medical Director (14 years’ experience; app. 400 trials executed as PI) working for a high-profile CRO in Germany.
He has particular attributes and expertise in:
- Planning and executing of first-in-human studies, cardiovascular (hypertension, heart failure), CNS (migraine, insomnia, Alzheimer´s disease), metabolism (hyperlipidemia, diabetes) and infections (HIV, Hepatitis B)
- Scientific advisor for sponsors during the study planning, execution as well as evaluation of studies
- Establishment and maintenance of contacts with representatives of regulatory authorities in Germany relevant for submission and approval of clinical studies
Krzysztof G. Jeziorski M.D., Ph.D., Assoc. Prof.
Member of Polish Association of Clinical Oncology, European Neuroendocrine Tumor Society and National Council of Neuroendocrine Tumors Register, liaison in EORTC, PI in international clinical trials and projects, academic teacher (Medical University in Warsaw, Centre of Postgraduate Medical Education, Polish Academy of Science), major advisor of PhD thesis and medical specializations, lecturer of medical conferences and trainings, from over 30 years involved in clinical oncology and gastroenterology, over 127 scientific publications (IF=97,640).
Agnieszka Kulesza has over 15 years’ experience in early phase drug development and was directly involved in execution of over 120 clinical trials. She is an expert in patient-centric initiatives & campaigns services.
Aleksandra Dalecka is an attorney at since 2004. She is also a graduate of the Warsaw University, Law and Administration Faculty and Centre for the Study of English and European Law. She successfully completed the Good Clinical Practice course at Ashford and St. Peter’s Hospitals, which was organized in cooperation with the Royal Holloway University of London. She specializes at contract drafting and negotiating as well as in legal aspects of clinical research. Fluent English and Russian speaker.
He has 20 years of experience in creating and managing projects in the field of Corporate Social Responsibility and Media Relations. Currently, he runs the Angels of Mercy Foundation, which supports the only hospice in Lithuania, centres for homeless people and the Polish National Team in Amp Futbol. He is the author of numerous reports, guides and articles regarding CSR, marketing, sales and psychology. A longtime editor of B2B and B2C magazines in the Medical, FMCG and Spirituality sectors. The creator of corporate narratives and social content for international corporations. Privately: husband and father, fan of the Silmarillion children and the work of the Desert Fathers.
Associated with clinical trials for 19 years. Has extensive experience in B2B market and retail services. Specializes in sales support tools and reaching groups of trials participants. He deals with building recruitment strategies and corporate image activities.